Project Grant 2210021
Award Date
9/15/22
Completion Date
8/31/23
Dollars Obligated
$256K
Federal Agency
National Science Foundation
Federal Grant Program
47.084
Assistance Type
Project Grant
Place of Performance
Baltimore, MD 21230, USA
Similar Awards
This National Science Foundation (NSF) Technology, Innovation, and Partnerships (CFDA 47.084) Project Grant award of $274,990 to Scorpido Photonics aims to develop a novel optical method for rapid and accurate point-of-care cancer diagnosis through the use of plasmonic nanobubbles. The project seeks to integrate this plasmonic nanobubble sensor technology into a standard endoscope to enable minimally invasive, non-invasive detection of microscopic tumors during lung cancer diagnostic procedures....
This federal Project Grant award, valued at $568,151.00 and provided by the National Cancer Institute (NCI) under the Cancer Detection and Diagnosis Research program (CFDA 93.394), supports the development of a real-time photoacoustic imaging platform to accurately detect and characterize the aggressiveness of prostate cancer tumors. The project, awarded to the Regents of the University of Michigan, aims to optimize photoacoustic nanoparticle probes for tumor microenvironment imaging and...
This $256,000 National Science Foundation Project Grant under the Engineering (47.041) program will support the development of an artificial intelligence-based system for analyzing multiparametric magnetic resonance imaging (MRI) scans to detect prostate lesions. The awardee, Taurus Diagnostics, Inc., will create a novel prostate cancer diagnostic platform leveraging artificial intelligence image analysis for high sensitivity and specificity. Key objectives include developing methods to...
This $449,996 Project Grant award from the National Science Foundation's Engineering program (CFDA 47.041) aims to develop a highly sensitive, low-cost sensor platform to detect circulating tumor DNA (ctDNA), a key biomarker for early cancer diagnosis. The project, conducted in collaboration with researchers at the University of Cambridge, combines microwave photonics (MWP) and polymer-based micro-ring resonator technology to create a portable and affordable solution for point-of-care cancer...
This $274,594 Project Grant award from the National Science Foundation (NSF) Technology, Innovation, and Partnerships (CFDA 47.084) program supports research and development of an innovative technology for cancer diagnosis and treatment. The project aims to improve molecular profiling and clinical laboratory testing of cancer samples by optimizing microdissection techniques. The research will focus on modeling and optimizing the opto-thermal-mechanical interactions involved in microdissection to...
This Project Grant from the National Science Foundation's Technology, Innovation, and Partnerships program (CFDA 47.084) provides $275,000 to Dcan Biosciences LLC to develop an advanced microfluidic system for cancer diagnosis and monitoring. The system aims to isolate and assess circulating tumor cells (CTCs) and CTC clusters (CTCCs) from patient blood samples to enable highly sensitive and accurate liquid biopsies. Key objectives include designing a hybrid microfluidic device for...
The National Science Foundation awarded Pensievision, Inc. $255,947 under the Technology, Innovation, and Partnerships program (CFDA 47.084) to develop an endoscopic 3D imaging system for evaluating cancers and disorders of the esophagus and pharynx. The Small Business Innovation Research Phase I project will combine liquid lens technology, artificial intelligence software, and astronomical imaging techniques to generate three-dimensional images of early-stage esophageal and throat tumors....
This National Science Foundation (NSF) Technology, Innovation, and Partnerships (CFDA 47.084) Project Grant award of $275,000 to Lightfinder Inc. aims to develop a silicon photonic optical coherence tomography (OCT) imager for pathology diagnostics. The primary objective is to create a high-performance, portable, and cost-effective imaging solution by integrating all optical components onto a single silicon chip. The research will address key technical challenges such as achieving high...
The National Science Foundation (NSF) awarded a $274,750 Small Business Innovation Research (SBIR) Phase I grant to Amplified Sciences Inc. on March 15, 2024 under the NSF Technology, Innovation, and Partnerships (CFDA 47.084) program. The project aims to develop a surface-enhanced Raman spectroscopy (SERS)-based diagnostic platform to detect and monitor multiple inflammatory biomarkers associated with various cancers. Key objectives include: 1) synthesizing ultrasensitive SERS-active dye...
This National Science Foundation (NSF) Technology, Innovation, and Partnerships (CFDA 47.084) award provides $275,000 to Lensguide Imaging Technology Inc. to develop a miniaturized, 100 μm diameter optical imaging microendoscope for in vivo deep tissue imaging up to 3 mm depth with subcellular resolution. The product will enable researchers to visualize biological dynamics in live animals beyond the superficial tissue layers, facilitating new discoveries across biomedical fields. This SBIR Phase...